serena williams glp 1 company Why Went Public About Losing Weight With Zepbound Serena Williams comeback has GLP-1
Description
In its Complete Response Letter (CRL), the FDA cited undisclosed product quality and master filing issues for the infusion device, which is proprietary to the device manufacturer, according to Supernus announcement
Two oral options arrived in 2026: The Wegovy oral pill (oral semaglutide) launched in January 2026
Watch for signs of hair thinning , which can indicate protein or caloric deficit
:max_bytes(150000):strip_icc():focal(748x241:750x243)/Serena-Williams-1-012726-2698f17c5ab647929a79194c436d85ea.jpg)
This can be paradoxical because weight loss generally improves joint health over time, but the transition period can be uncomfortable
